                         SEQUENCE LISTING

<110>  DKFZ Deutsches Krebsforschungszentrum, Stiftung des 
       ffentlichen Rechts
 
<120>  uPAR selective contrast agent for magnetic resonance imaging

<130>  DK64425PC

<150>  EP06121180.1
<151>  2006-09-25

<160>  14    

<170>  PatentIn version 3.3

<210>  1
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  1

Ser Glu Lys Thr Asn Arg Thr Leu Ser Tyr Arg Thr Gly Leu Lys 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  2

Gln Gly Asn Ser Gly Arg Ala Val Thr Tyr Ser Arg Ser Arg Tyr 
1               5                   10                  15  


<210>  3
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  3

Cys Asn Lys Tyr Phe Ser Asn Ile Cys Trp 
1               5                   10  


<210>  4
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  4

Ser Glu Lys Thr Asn Arg Thr Leu Ser Tyr Arg Thr Gly Leu Lys Cys 
1               5                   10                  15      


<210>  5
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  5

Gln Gly Asn Ser Gly Arg Ala Val Thr Tyr Ser Arg Ser Arg Tyr Cys 
1               5                   10                  15      


<210>  6
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  6

Gly Gly Gly Cys Asn Lys Tyr Phe Ser Asn Ile Cys Trp 
1               5                   10              


<210>  7
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  7

Pro Met Pro His Ser Leu Asn Phe Ser Gln Tyr Leu Trp Tyr Thr 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  8

Ser Gln Thr Gly Thr Leu Asn Thr Leu Phe Trp Asn Thr Leu Arg 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  9

Met His Arg Ser Leu Trp Glu Trp Tyr Val Pro Asn Gln Ser Ala 
1               5                   10                  15  


<210>  10
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  10

Cys Gly Pro Met Pro His Ser Leu Asn Phe Ser Gln Tyr Leu Trp Tyr 
1               5                   10                  15      


Thr 
    


<210>  11
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  11

Cys Gly Ser Gln Thr Gly Thr Leu Asn Thr Leu Phe Trp Asn Thr Leu 
1               5                   10                  15      


Arg 
    


<210>  12
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  12

Cys Gly Met His Arg Ser Leu Trp Glu Trp Tyr Val Pro Asn Gln Ser 
1               5                   10                  15      


Ala 
    


<210>  13
<211>  17
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  13

Gln Gly Asn Ser Gly Arg Ala Val Thr Tyr Ser Arg Ser Arg Tyr Leu 
1               5                   10                  15      


Glu 
    


<210>  14
<211>  18
<212>  PRT
<213>  artificial sequence

<220>
<223>  uPAR binding peptides

<400>  14

Gln Gly Asn Ser Gly Arg Ala Val Thr Tyr Ser Arg Ser Arg Tyr Leu 
1               5                   10                  15      


Glu Cys 
        


